menu search

XBI / This "Golden" Technical Indicator is Triggering Across the Market

This
A Golden Cross is a simple, yet effective technical indicator. Andrew Rocco explains how to use it and relates it back to the current market. Read More
Posted: Jan 26 2023, 09:47
Author Name: Zacks Investment Research
Views: 111587

XBI News  

It doesn't seem like there's too much momentum for healthcare stocks, says Mizuho's Jared Holz

By CNBC Television
October 23, 2023

It doesn't seem like there's too much momentum for healthcare stocks, says Mizuho's Jared Holz

Jared Holz, Mizuho healthcare sector specialist, joins 'Squawk on the Street' to discuss how Holz broadly sees the biotechnology sector, what distills more_horizontal

Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

By Zacks Investment Research
October 17, 2023

Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

The SPDR S&P Biotech ETF (XBI) made its debut on 01/31/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care more_horizontal

Should You Invest in the SPDR S&P Biotech ETF (XBI)?

By Zacks Investment Research
September 18, 2023

Should You Invest in the SPDR S&P Biotech ETF (XBI)?

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the SPDR S&P Biotech ETF (XBI), more_horizontal

Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

By Zacks Investment Research
August 15, 2023

Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

A smart beta exchange traded fund, the SPDR S&P Biotech ETF (XBI) debuted on 01/31/2006, and offers broad exposure to the Health Care ETFs category of more_horizontal

Should You Invest in the SPDR S&P Biotech ETF (XBI)?

By Zacks Investment Research
July 18, 2023

Should You Invest in the SPDR S&P Biotech ETF (XBI)?

Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthc more_horizontal

ARKG: Outperforming XBI, Reasonably Valued With Technical Upside Potential In 2H

By Seeking Alpha
July 2, 2023

ARKG: Outperforming XBI, Reasonably Valued With Technical Upside Potential In 2H

ARKG: Outperforming XBI, Reasonably Valued With Technical Upside Potential In 2H more_horizontal

XBI: A Vehicle For The Transformative Benefits Of Artificial Intelligence Within Biotechnology

By Seeking Alpha
July 1, 2023

XBI: A Vehicle For The Transformative Benefits Of Artificial Intelligence Within Biotechnology

Artificial Intelligence stands to revolutionize drug discovery and manufacturing in the biotech industry, promising faster, cost-effective processes, more_horizontal

Buy This ETF Before June Runs Out

By Schaeffers Research
June 16, 2023

Buy This ETF Before June Runs Out

Subscribers to  Chart of the Week  received this commentary on Sunday, June 11. more_horizontal


Search within

Pages Search Results: